Sanofi and Denali to Develop Small Molecules to Treat ALS, Other Diseases | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From alsnewstoday.com - November 8, 2018 4:20 AM
Denali Therapeutics and Sanofi are working to advance in clinical trials small molecules that block the RIPK1 enzyme to possibly treat diseases like ALS.